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Abstract 
This systematic review aimed to collect, evaluate, and synthesize the research on 
muscle dysmorphia (MD) post official recognition as a specifier for body dysmorphic 
disorder (BDD) in the DSM-5, and provide recommendations for future research. Literature 
searches were conducted in four databases to see if inclusion criteria were met. Results 
revealed 33 studies meeting inclusion criteria, none of which utilized DSM-5 criteria for MD 
and/or acknowledged the criterion in their research. Few studies acknowledged the 
association between MD and BDD, and the methodological quality of recent MD research 
was considered low due to a lack of clinical samples, measurements not using validated cut-
off scores, and the research designs. In conclusion, future MD research is encouraged to 
utilize DSM-5 diagnostic criteria to better inform clinical practice; and significantly improve 
the methodological quality. As such, more effective treatment options may be developed 
reducing the risk of health harming consequences in these individuals. 
 
Keywords: systematic review; methodological quality; relationships; body dysmorphic 
disorder 
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Muscle Dysmorphia Research Neglects DSM-5 Diagnostic Criteria 
 
In western countries, and in particular the United States, research has revealed the 
mesomorphic (muscular and athletic) and hyper mesomorphic (extreme muscular size and 
definition) physique to be the most desirable body types amongst males (e.g., Olrich, 1999; 
Tucker, 1983; Grogan, 2016). From this, such desirable (or unrealistic in some cases) 
physiques may have accumulated the swift of diagnostic mental disorders focusing on the 
body. One mental disorder focusing on the body and muscularity is muscle dysmorphia (MD). 
MD is defined as a preoccupation with muscularity where an individual (predominantly 
observed in males) sees themselves as not muscular enough or ‘too small’ even though in 
many cases these individuals are above average in muscle size and strength (Pope, Katz, & 
Hudson, 1993). Such obsessions with the body may become serious clinical disorders, and 
can result in loss of employment (Pope, Phillips, & Olivardia, 2000), loss of family and 
friends (e.g., falling out with people close to you; Olivardia, 2007), or in worst cases result in 
suicidality and death (Phillips & Menard, 2006) due to the preoccupation. Initially, MD was 
termed ‘reverse anorexia’ due to its explored similarities with anorexia nervosa, where 
individuals with anorexia nervosa see themselves as bigger and ‘fatter’ than they really are, 
and individuals with ‘reverse anorexia’ see themselves as small and weak when in reality they 
are large and muscular (Pope et al., 1993). In subsequent years, Pope, Gruber, Choi and 
Olivardia (1997) suggested MD to be a form of body dysmorphic disorder (BDD), followed 
by proposed diagnostic criteria for the disorder which has remained more or less unchanged 
ever since: (1) an individual has a preoccupation with not being sufficiently lean and 
muscular; (2) the preoccupation with muscularity and leanness causes significant distress or 
impairment in daily functioning; and (3) the main focus of the preoccupation and behaviours 
is on perceiving themselves as ‘too small’ or inadequately muscular.  
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From this research, MD was ‘born’ within the BDD spectrum of psychopathology, and 
the category BDD is now receiving a great deal of research (e.g., Angelakis, Gooding, & 
Panagioti, 2016; Phillips et al., 2010). BDD is classified as a form of ‘hypochondriacal 
disorder’ in the somatoform section in the International Statistical Classification of Diseases 
and Related Health Problems Tenth Edition (ICD-10; World Health Organization, 1992). 
More recently, BDD was classified under the section of ‘Obsessive-Compulsive and Related 
Disorders’ in the Diagnostic and Statistical Manual of Mental Health Disorders Fifth Edition 
(DSM-5), defined as a preoccupation with perceived appearance defects or flaws (American 
Psychiatric Association, 2013). In DSM-5, BDD holds the following diagnostic criteria: (1) 
preoccupation with appearance where an individual is preoccupied with one or more absent or 
slight defects in their physical appearance (e.g., one or more specific body-parts or 
muscularity); (2) repetitive and compulsive behaviours related to the concerns with their 
physical appearance (e.g., constant mirror checking); and (3) the preoccupation must cause 
impairment or distress in social, occupational or other areas of functioning (e.g., avoids social 
settings due to the concerns with physical appearance). It has been suggested that a patient 
who meets all BDD diagnostic criteria should also be evaluated for MD (Pope et al., 2000; 
Pope et al., 2005).  
For the first time, and what can be considered a breakthrough year for MD, the 
American Psychiatric Association (2013) officially recognized MD as a specifier for BDD 
under the section of ‘Obsessive-Compulsive and Related Disorders’ in the DSM-5. In this 
case, the body, level of muscularity and leanness is the obsession, and the compulsion is the 
drive and desire to achieve the neccessary levels of muscularity and leanness (Pope et al., 
2000). Compulsions (excessive repetitive behaviours) typical to BDD include e.g., mirror 
checking and reassurance seeking, but excessive weightlifting is more specific to MD 
providing support for MD being a specifier for BDD (American Psychiatric Association, 
MUSCLE DYSMORPHIA POST DSM-5 5 
2013). The official recognition of MD in the DSM-5 is a result of the significant amount of 
research and interest among investigators, which in turn has informed the current official 
recognition of the diagnostic criteria and classification of MD. However, in the ICD-10, MD 
is recognized with other BDD conditions in section F45.2, nonetheless the World Health 
Organisation have decided to exclude MD under the section of BDD in the ICD-11 due to an 
absence in evidence supporting MD’s clinical utility (see Veale & Matsunaga, 2014).  
Expanding on the diagnostic criteria of MD, the research to date has explored 
relationships associated with the condition, and confirmed the characteristics of an individual 
with MD. In summary, these characteristics and relationships include an obsession with 
building more muscle mass (Choi, Pope, & Olivardia, 2002; Pope et al., 1997; Pope et al., 
2000), excessive and compulsive exercise (Leone, Sedory, & Gray, 2005), appearance 
checking (e.g., mirror checking) and protection (e.g., wearing baggy clothes to hide physique; 
Leone et al., 2005; Mosley, 2009), drug abuse (e.g., anabolic androgenic steroids AAS; 
Mosley, 2009; Olivardia, Pope, & Hudson, 2000), extreme dieting (Leone et al., 2005), 
impaired daily functioning (e.g., struggling to get daily tasks done such as study or work; 
Cella, Iannaccone, & Cotrufo, 2012), depression, anxiety, and high levels of stress (Leone et 
al., 2005). However, limitations do exist with most studies investigating MD relationships and 
characteristics, where research participants are only examined on one occasion. As a result, 
very little is known about temporal aspects (e.g., day-to-day differences) related to the 
condition, and symptom-stability (e.g., differences in presence of symptoms). At present, only 
one study has partially studied temporal aspects and symptom-stability in MD. Thomas, Tod 
and Lavallee (2011) looked at the influence of a training session in young males, and 
compared MD symptoms on a rest-day and after a training session. They found evidence of 
that the participants had more symptoms of MD on a rest-day compared to following a 
training session, indicating that symptoms of MD may be influenced by situational variables. 
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With MD comes consequences that may negatively affect day-to-day quality of life, 
where individuals with MD tend to experience extreme anxiety in the event of missing a 
workout (Olivardia et al., 2000; Pope et al., 2000). Consequently, daily chores and activities 
are disrupted because of the obsession with building muscles. Research has shown that 
individuals with MD have lost their jobs (e.g., the workout schedule interferes with 
employment working hours; Pope et al., 2000), and loss of family and friends where these 
relationships are destroyed due to interference with their workout schedules (Olivardia, 2007). 
These individuals may also possess an extreme attention to diet, calculating all nutritional 
values, and may find it difficult to eat out with family and friends, fearing this could interrupt 
maximum muscle growth (Mosley, 2009; Olivardia et al., 2000). In addition, individuals at 
risk of developing MD (i.e., those not yet meeting full diagnostic criteria), or individuals with 
MD are also more likely to start using drugs (in particular AAS) to enhance their muscle 
hypotrophy beyond what is naturally possible (Mosley, 2009; Pope & Katz, 1994; Pope, 
Kanayama, Ionescu, & Hudson, 2004).  
Furthermore, some individuals may have a predisposition for developing MD, or 
experienced e.g., a traumatic event that may contribute to development. Gruber and Pope 
(1999) suggested that MD may be a reaction to physical abuse as one risk factor in females, 
where these women want to ‘bulk up’ for increasing the chance of defending themselves in 
the event of a future attack. The researchers further suggested that feeling weaker compared 
to friends and peers, or feeling vulnerable in a hostile environment may contribute to MD 
development. Individuals with a predisposition of obsessive compulsive disorder symptoms 
may also be more likely to develop MD (e.g., exercising to build muscle becomes the 
compulsion in MD cases), and negative childhood or teenage-years eperiences (e.g., bullying 
or loosing a family member; Pope et al., 2000). Moreover, there are indications in the 
literature that those who engage in weight training at the gym with the purpose of 
MUSCLE DYSMORPHIA POST DSM-5 7 
changing/enhancing appearance are more at-risk of developing MD compared to those with 
performance driven motives (e.g., Murray, Griffiths, Mond, Kean, & Blashill, 2016; Skemp, 
Mikat, Schenk, & Kramer, 2013). Nevertheless, beyond this the literature is rather limited in 
explaining background and reasons for why some individuals more than others may develop 
MD (Tod, Edwards, & Cranswick, 2016).  
A significant limitation with the research on MD is the methodological quality, which 
does not hold a high level, and therefore continues to threat knowledge advancement. Dos 
Santos Filho et al. (2016) conducted a review amongst 34 studies published between 1997 and 
2014, all of which were graded at the lowest level (level IV; National Health and Medical 
Research Council NHMRC, 2008) of methodological quality due to research designs (cross-
sectional and case-series). The NHMRC provide guidelines for levels of evidence, with 
systematic reviews of level II studies graded at level I evidence (highest level), and cross-
sectional, single descriptive, and case series designs graded at level IV (within the lowest 
levels; NHMRC, 2008). Other factors threatening the methodological quality are the use of 
small samples, poor sample descriptions (e.g., labelling participants ‘bodybuilders’ when 
really they are ‘non-competitive gym-goers’), large variation in control samples, and non-
specific MD measurements (Tod et al., 2016). Measurements of the sole drive for muscle size 
(i.e., Drive for Muscularity Scale; McCreary & Sasse, 2000) do not assess all features 
associated with MD. Wanting to increase muscle mass or being dissatisfied with level of 
muscularity is not synonymous with distress (Kimmel & Mahalik, 2004; Morrison, Morrison, 
& McCann, 2006).  
Furthermore, prior to MD being officially recognized in 2013 as a specifier for BDD 
in the DSM-5, the relationship between MD and other types of BDD has received limited 
research (Phillips et al., 2010). Hitzeroth, Wessels, Zungu-Dirwayi, Oosthhuizen, and Stein 
(2001) reported 5 of 15 bodybuilders with MD also showed other symptoms of BDD. Further 
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studies (e.g., Phillips & Diaz, 1997; Pope et al., 1997; Pope et al., 2005) have suggested 9.3% 
of 193 males, 22.2% of 63 males, and 25% of 95 males with BDD also had MD, respectively. 
Despite strong evidence of MD being a specifier for BDD, authors of more recent research 
since the turn of the 21st century disagree as to whether MD should be classified as an 
obsessive-compulsive disorder, BDD, or as an eating disorder (e.g., Maida & Armstrong, 
2005; Mosley, 2009; Murray et al., 2012; Murray, Rieger, Touyz, & De la Garza García, 
2010; Nieuwoudt, Zhou, Coutts, & Booker, 2012). Murray and Touyz (2012) debate that the 
phenomenology of MD is markedly different to the features of BDD, such as presentations of 
BDD do not generally include diet and exercise related psychopathology. Additionally, others 
argue that the evidence on MD does yet not confirm the validity, nosological classification, 
and inclusion for MD as a new mental health disorder (e.g., Dos Santos Filho et al., 2016). 
Out of 34 studies reviewed between 1997 and 2014, only nine of these acknowledged MD as 
a specifier for BDD, and most did not discuss the nosological status of MD or considered the 
evidence to be too weak for any psychiatric classification (Dos Santos Filho et al., 2016). 
From this research, the diagnostic continuum remains to be further explored to inform 
clinical practice. Although, the current diagnostic criteria for MD is informative on the 
characteristics and behaviours associated with the condition, clinical utility is limited with the 
lack of evidence concerning the degree to which these behaviours and characteristics are 
existent in pathological presentations (Murray & Baghurst, 2013). Understanding the present 
status, research direction, and the needs for improvement in MD research is essential. With 
this, further support of MD being a specifier for BDD, the methodological quality, 
background and reasons for individuals developing MD, relationships between MD and other 
variables, and the consequences of living with the condition, may help show how MD can 
improve clinical utility and practice.  
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With the existing reviews on MD covering the literature up until October 2014 (Dos 
Santos Filho et al., 2016; Suffolk, Dovey, Goodwin, & Meyer, 2013), there is now a need for 
further extension of this knowledge base and reorganizing established knowledge with the 
release of the DSM-5 on 18th May 2013, and MD being officially recognized as a specifier for 
BDD that year (American Psychiatric Association, 2013). As such, 2013 may be viewed as a 
breakthrough year for the disorder, and may have accumulated some changes in the way MD 
research is now being conducted and understood. Whether or not a substantial change in 
research on MD is existent post DSM-5, a mutual and global awareness of the state of the 
research on MD is crucial for researchers in the field, which may lead to advancing 
knowledge more effectively. Therefore, the aim of this systematic review is to collect, 
evaluate, and synthesize the research on MD post its official recognition in the DSM-5 related 
to (a) methodological quality; (b) relationships between MD and other variables; (c) 
consequences of living with the condition; (d) background and reasons for individuals 
developing MD; and (e) MD’s association with BDD. A second aim is to provide 
recommendations for future research.  
Methods 
Literature Search 
A systematic literature search was performed using the following online electronic 
EBSCOhost Research Databases up until December 2017: PubMed, MEDLINE, PsycINFO, 
and SPORTDiscus. The search strategy adopted used the following search terms in ALL 
FIELDS: muscle dysmorphi* disorder OR muscle dysmorphia OR bigorexia. The search was 
limited to studies published in 2013 as the oldest and in 2017 as the newest in peer-reviewed 
scholarly journals only. In addition, manual searches in subject-related journals were 
conducted to track any neglected studies from the major search strategy. These searches 
yielded no additional studies to be included. Finally, lists of references from the majority of 
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the retrieved studies were screened to trace any additional studies meeting the inclusion 
criteria for the present systematic review. This search yielded no additional studies to be 
included.  
Inclusion Criteria 
For studies to be included they should have a descriptive or analytical design and 
report on at least one or more of the following: (1) relationships between MD and other 
variables; (2) reasons or background for developing or having MD; (3) consequences of living 
with MD; or (4) provided evidence for the association between MD and BDD with or without 
utilizing DSM-5 criteria. Studies of all languages were considered for inclusion. 
Exclusion Criteria 
 Studies submitted and published prior to 18th May 2013 (DSM-5 release date), studies 
of no original research, theoretical studies, studies utilizing no human samples (e.g., analysing 
photos in the media), studies validating MD measurements, clinical or applied studies (e.g., 
case reports), or studies not specifically investigating MD but rather only body dissatisfaction 
in general or only one feature of MD (e.g., extreme dieting or exercise dependence) were 
excluded.  
Selection Process and Data Extraction 
Once all studies were identified across the included databases, study titles and 
abstracts were screened for inclusion and exclusion criteria by the first reviewer. The second 
reviewer consulted the identified studies, and confirmed the studies selected by the first 
reviewer for eligibility. Studies selected for eligibility were further screened in more detail 
through full-text screening to identify further inclusion and exclusion of studies (Figure 1). To 
evaluate the methodological quality of the included studies, country where the research was 
conducted, study design, measurements employed to participants, and sample characteristics 
(n, sex, and age) were extracted and synthesised. In addition, study designs were graded 
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according to the levels of evidence by the NHMRC (2008) guidelines, although the 
methodological quality was primarily evaluated based on sample characteristics and 
measurements employed to the participants in the included studies. Furthermore, studies’ 
main results and/or conclusions were extracted pertaining to at least one or more of the 
inclusion criteria (see inclusion criteria 1 to 4).  
Results 
Study Characteristics 
In total, 210 records were identified between January 2013 and December 2017 in 
PubMed (n = 68), Medline - via EBSCO (n = 64), PsycINFO (n = 59), and SPORTdiscus (n = 
19) with some overlap between databases. The screening process revealed 33 studies meeting 
inclusion criteria (see Figure 1 for the inclusion process). The included studies revealed the 
following characteristics: they were conducted in Europe (n = 11; Msample size = 267 [one study 
did not report n], 63.6% male, 36.4% mixed gender participants; Spain n = 5; Msample size = 
356; 60% male and 40% mixed gender participants, Italy n = 4, Msample size = 251; 66.6% 
male and 33.4% mixed gender participants, Poland n = 1; Msample size = 30; 100% mixed 
gender participants, Germany n = 1; Msample size = 100; 100% male participants), United 
States (n = 9; Msample size = 342 55.5% male, 11.1% female, 33.3% mixed gender 
participants), Australia (n = 7; Msample size = 267 80% male, 20% mixed gender 
participants), United Kingdom (n = 3; Msample size = 187 100% male participants), South 
America (n = 2; Msample size = 327 50% male, 50% mixed gender participants; Brazil n = 1; 
Msample size = 182; 100% mixed gender participants, Argentina n = 1; Msample size = 472; 100% 
male participants), and China (n = 1; Msample size = 782 100% male participants).  
Methodological Quality 
Most studies enrolled non-clinical samples (n = 32; 97%), being physically active 
university students, weight lifters, gym-goers, athletes, and bodybuilders. One study (Macik 
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& Kowalska, 2015) enrolled a clinical sample of MD diagnosed participants. Other samples 
consisted of current or recent AAS users (Murray et al., 2016), military personnel (Campagna 
& Bowsher, 2016), and personal trainers (Diehl & Baghurst, 2016). A total of 11 (33.3%) 
studies enrolled mixed samples of males and females, 21 (63.6%) studies enrolled only males, 
and only 1 study enrolled solitary female participants (Hale, Diehl, Weaver, & Briggs, 2013). 
The participants’ age ranged from 13-59 years across all studies, although the majority of the 
studies (88.6%) had a minimum age of 18 years for inclusion. Finally, the sample size in the 
studies ranged from 32-1150 participants, of which the majority (42.4%) had a sample size 
between n = 100-200. Additionally, sample sizes between n = 0-100 (18.1%), between n = 
200-500 (15.1%), and n = 500< (21.2%) were observed. 
The most frequently assessed measures of MD were the Muscle Appearance 
Satisfaction Scale (MASS; n = 10), Muscle Dysmorphia Inventory (MDI; n = 8) and Muscle 
Dysmorphic Disorder Inventory (MDDI; n = 7). Other studies also used the Muscle 
Dysmorphia Questionnaire (MDQ; n = 2), Muscle Dysmorphia Symptom Questionnaire 
(MDSQ; n = 1), Dysmorphia Concern Questionnaire (DCQ; n = 1), Bodybuilding 
Dependence Scale (BDS; n = 1), Escala de Satisfacción Muscular (ESM; n = 2), Drive for 
Muscularity Attitudes Questionnaire (DMAQ; n = 1), Drive for Muscularity Scale-Spanish 
Version (DMS-S; n = 1), for the investigation of MD. In addition, the majority of the included 
studies also used measures of a variety of mental health disorders and factors associated with 
MD. Primarily, the Eating Disorder Examination – Questionnaire (EDE-Q; n = 2), Eating 
Attitudes Test – 26 (EAT-26; n = 4), Exercise Dependence Scale (EDS; n = 1), Body 
Dysmorphic Disorder Questionnaire (BDDQ; n = 1), and Body Dysmorphic Disorder Scale 
(BDDS; n = 1). 
Furthermore, most studies had a cross-sectional or survey-based research design (n = 
26; 78.8%), whilst four studies had a descriptive/correlational design, one study had a 2x2x2 
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between subject design, one study adopted a mixed methods design, and another used an 
experimental research design. The methodological quality of the majority of the included 
studies (78.8%) were graded at the lowest level (level IV) of quality, consistent with NHMRC 
(2008) guidelines.  
Relationships Between MD and Other Variables 
In total, 24 studies (77.7% of the total) reported their main significant (significance 
level of minimum p < .05) relationships between MD symptomatology and a wide range of 
different variables. These included eating disorder symptoms (n = 5), supplements to get more 
muscular (n = 4), body/muscle dissatisfaction (n = 3), peer/family influence (n = 3), BDD 
symptoms (n = 2), and media influence (n = 2). Other less reported relationships with MD 
were bullying (n = 1), bulimia (n = 1), drive for thinness (n = 1), socially prescribed 
perfectionism (n = 1), distant and close male preferences of muscularity (n = 1), negative 
quality of life (n = 1), set shifting difficulties and weak central coherence (n = 1), being a 
student (n = 1), body mass index (BMI; n = 1), stigmatization (n = 1), muscle checking (n = 
1), bodily ideals (n = 1), psychopathologic variables (n = 1), male body attitudes (n = 1), age 
(n = 1), social comparison tendencies/withdrawal (n = 1), and upper body clothing (n = 1).  
Consequences 
Eleven studies (33.3% of the total) provided data and discussion around the 
consequences of being at risk of developing MD (those not yet meeting full diagnostic 
criteria) - or having MD. As a consequence, at risk individuals or individuals with MD may 
experience: diet and excessive supplement intake (n = 4), exercise dependence (n = 2), 
negative self-image (n = 3), physique protection (n = 2; Baghurst et al. 2014 questions this 
trait of MD), disordered eating (n = 1) poorer quality of life (n = 1), and lower desire for 
social interaction (n = 1).  
Background and Reasons 
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Almost half of the studies (n = 16; 48.5% of the total) provided evidence for 
background and reasons for MD development. The most common were: focus on appearance 
enhancement (n = 2), and pre-existing perfectionistic attitudes (n = 2). Less common were: 
AAS use because of appearance related concerns (n = 1), perceived female preferences for 
level of muscularity (n = 1), positive beliefs about MD may contribute to development (n = 
1), exercise and sport science school enrolment (n = 1), perceived ideal physique (n = 1), high 
levels of alexithymia (n = 1), non-gender specific in personal trainers (n = 1), age-group of 
17-19 years (n = 1), insecure avoidant attachment style (n = 1), stop training (n = 1; e.g., 
former weight trainers), self-perception of being too thin or too big (n = 1), global 
psychopathology (n = 1), and addicted to working out (n = 1). 
MD Associations with BDD 
A total of seven (21.2% of the total) studies discussed MD associated - or not - with 
BDD. None (n = 0) of the studies utilized DSM-5 criterion in their research. Three studies 
(Campagna & Bowsher, 2016; Macik & Kowalska, 2015; Nieuwoudt, Zhou, Coutts, & 
Booker, 2015) positively associated BDD (DSM-4 criterion utilized) with MD. Two studies 
neglected BDD criterion, and instead (a) linked MD with anorexia nervosa providing a 
parallel with eating disorders, and applied the trans-diagnostic model of eating disorders to 
enhance understanding of MD (Griffiths, Mond, Murray, & Touyz, 2015); and (b) compared 
MD with eating disorder psychopathology and confirmed the association (Mitchell et al., 
2017). Moreover, two studies also questioned the current proposed MD criteria: Xinhong et 
al. (2015) suggested MD might have other influential factors other than the ones from BDD 
and eating disorders, and Nieuwoudt et al. (2016) utilized MD diagnostic criteria by Pope et 
al. (1997), and BDD DSM-4 criterion, providing evidence to question the acceptance of the 
proposed MD criteria (see Table 1 for an overview of all results). 
Discussion 
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This systematic review aimed to collect, evaluate, and synthesize the research on MD 
post the disorder was recognized as a specifier for BDD in the DSM-5 on the 18th May 2013 
relating to several areas. Most significantly, none of the included studies utilized DSM-5 
criteria in their research which was an unanticipated finding, and few studies acknowledged 
MD being associated with BDD. The current systematic review also identified several 
concerns with the methodological quality of the research on MD. If these concerns are not 
dealt with, they will continue to substantially limit knowledge advancement in the field. 
Finally, relationships between MD and other variables, consequences, and background and 
reasons for MD development have accumulated little advanced knowledge since DSM-5 
recognition. 
Most studies investigating MD have been conducted in the United States post its 
literary inception (Dos Santos Filho et al., 2016), however, the present systematic review 
found that, and according to geographical regions, European countries produced more studies 
(n = 11) compared to that of Unites States (n = 9), Australia (n = 7), United Kingdom (n = 3) 
South America (n = 2), and China (n = 1) in recent years post the DSM-5 release. Similar 
results have been found by Tod et al. (2016), who stated MD has sparked global interest 
among researchers with the significant amount of non-English publications. Now with this 
global interest on MD, a logical next step may be cross-cultural comparisons across 
noticeably different cultures (e.g., United Kingdom and China; Tod et al., 2016). Such data 
will provide more insight into the cultural differences, which in return may advance 
knowledge of the societal role in MD development and prevalence. Moreover, the majority 
(78.8%) of the included studies were of the lowest level of methodological quality, consistent 
with NHMRC (2008) guidelines, that is adopting a cross-sectional or survey-based research 
design. Most studies enrolled non-clinical males aged 18 years or older, and most studies had 
a sample size between 100-200 participants who were given the measurements MDDI, MDI 
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and MASS most frequently across the included studies. Most of these findings are consistent 
with previous results, with most studies on MD having typically a cross-sectional design, and 
enrolling non-clinical males labelled ‘weightlifters’, ‘gym-goers’, ‘students’, and 
‘bodybuilders’ (e.g., Dos Santos Filho et al., 2016; Suffolk et al., 2013; Tod et al., 2016). 
However, Dos Santos Filho et al. (2016) noted that most studies on MD between 1997 and 
2014 enrolled samples of less than 100 participants. On the contrary, an increase in sample 
sizes across the literature in recent years post DSM-5 recognition is observed with most 
studies enrolling samples of 100-200 participants (42.4% of the total) and 500< participants 
(21.2% of the total).  
Methodological quality as well as interpretation of results in MD research is further 
threatened with the existing MD measures, although valid, limitations exist. For example, not 
employing these measures with clinical samples, which then limits the discrimination between 
being ‘without MD’ and ‘with MD’ as a consequence, and the measures have no validated 
cut-off scores (Suffolk et al., 2013). Validating cut-off scores for the available MD 
measurements will be an important next step, which may advance prevalence reporting using 
mutual methods in classifying participants as either ‘with’ or ‘without’ MD. Additionally, in 
line with previous findings (Suffolk et al., 2013; Tod et al., 2016), several studies in the 
present systematic review also employed measures of drive for muscularity (e.g., DMAQ and 
DMS). Such measurements do not assess all features associated with MD, and therefore 
results from such studies may be questionable in measuring MD symptomatology as a desire 
for bigger muscles is not synonymous with distress (Kimmel & Mahalik, 2004; Morrison et 
al., 2006). Thus, efforts from researchers in improving the methodological quality on MD 
research other than increasing sample sizes are called for, as no significant methodological 
improvements across the literature has been observed for over two decades. 
MUSCLE DYSMORPHIA POST DSM-5 17 
Most studies in the present systematic review did report one or more relationships 
between MD and other variables. The most repeated relationships across studies were 
symptoms of MD correlating with eating disorder symptoms on both total and subscales of 
MD and eating disorder measures. As such, the association between MD and eating disorder 
symptomatology is confirmed, but the association needs further investigation with different 
populations and across genders to determine its significance. Other repeated relationships 
included e.g., body/muscle dissatisfaction, supplement usage, peer/family influence, and 
symptoms of BDD. Most of these support earlier findings (e.g., Leone et al., 2005; Olivardia 
et al., 2000). Exploring relationships are important, yet there is a need to examine these in 
more depth to strengthen and support the potential significance, and not only to report an 
association between two variables. More longitudinal data is recommended to further explain 
a significant relationship (e.g., day-to-day differences).  
Eleven studies reported evidence for the consequences for being at risk of developing- 
or having MD, with diet and excessive supplement intake, exercise dependence (i.e., addicted 
to working out), and negative self-image being the most reported consequences. The findings 
of these studies are in line with previous research (e.g., Mosley, 2009; Olivardia et al., 2000; 
Pope et al., 1997). However, for many years physique protection (e.g., hiding one’s physique 
in baggy clothing) has been suggested to be a characteristic and consequence of MD (e.g., 
Leone et al., 2005; Mosley, 2009). In this systematic review, one of the included studies 
(Baghurst et al., 2014) questioned physique protection as a characteristic of MD, with 
function and comfort being the most cited reasons for clothing worn among 114 weight 
training males. The researchers suggested physique protection as a characteristic of MD needs 
to be better understood and defined. Although clarification and definition are needed, it is 
likely that the result would be different if the study utilized males diagnosed with MD or 
professional bodybuilders, and not collegiate males who regularly workout. Individuals with 
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MD or at-risk bodybuilders may associate ‘comfortable clothing’ with ‘covering their 
physique’ more than undiagnosed recreational gym-goers would have, due to stage (e.g., early 
or late) of development. Physique protection may need to be examined in both clinical and 
non-clinical populations to draw significant comparisons. In addition, most studies that 
reported consequences of MD, were studies with a cross-sectional or descriptive design, 
where these participants were only assessed on one occasion. As such, without prospective 
studies (e.g., longitudinal), it is difficult to make assumptions about consequences.  
Furthermore, almost half of the included studies (48.5% of the total) reported 
background and reasons for developing MD in individuals. Several factors of background and 
reasons were reported in singular studies (e.g., self-perception of being too thin or too big, 
and insecure avoidant attachment style). However, the most repeated were focus on 
appearance enhancement (n = 3), and pre-existing perfectionistic attitudes (n = 3). There is 
now reason to suggest that if the main focus and goal when working out is to enhance 
appearance due to feeling insufficiently muscular, dissatisfied with current appearance, or 
having perfectionistic attitudes (e.g., chasing the ideal physique), the chance of developing 
MD may be higher (e.g., Dryer, Farr, Hiramatsu, & Quinton, 2016; Murray et al., 2016; 
Skemp et al., 2013). Additionally, one of the few studies enrolling participants under 18 years 
of age found that adolescents (17-19 years) had significantly more symptoms of MD 
compared to 15-16-year-old adolescents (Laghi, Magistro, Guarino, Baumgartner, & Baiocco, 
2013). This result may indicate that one specific age group in teenage years may be 
particularly vulnerable to symptoms of MD. However, beyond this the literature is limited in 
providing sufficient evidence of other factors of background and reasons for why some 
individuals develop MD. This is likely due to the complex mix of neurobiological, 
evolutionary and sociocultural factors that define the reasons for MD development.  
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With MD officially being recognized as a specifier for BDD in the DSM-5, it is likely 
to think this incredible achievement for the disorder would spark researchers’ interest in 
continuing the investigation of this association to increase MD’s clinical utility in the hope of 
getting MD classified an official clinical disorder. However, this is not the case, and it was 
detected that none of the studies utilized DSM-5 criterion in their research, and only three 
studies (Campagna & Bowsher, 2016; Macik & Kowalska, 2015; Nieuwoudt et al., 2015) 
positively associated BDD with MD, using DSM-4 criterion in non-clinical samples. 
Similarly, out of the 9 studies in Dos Santos Filho et al’s. (2016) review that associated MD 
with BDD, all of these were conducted with non-clinical samples (Cafri, Blevins, & 
Thompson, 2006; Cafri, Olivardia, & Thompson, 2008; Choi et al., 2002; Gruber & Pope, 
1999; Hildebrandt, Alfano, & Langenbucher, 2010; Hitzeroth et al., 2001; Pope et al., 2005; 
Soler, Fernandes, Damasceno, & Novaes, 2013; Wolke & Sapouna, 2008). Examining the 
association between MD and BDD in more clinical populations may add to our understanding 
of MD being a specifier for BDD. 
 Furthermore, two studies in this review (Griffiths et al., 2015; Mitchell et al., 2017) 
linked MD with eating disorder psychopathology, and two studies (Nieuwoudt et al., 2016; 
Xinhong et al., 2015) also questioned the current proposed MD criteria. Hence, the support 
for MD being a specifier for BDD has limited support in the literature after being recognized 
in the DSM-5. A detected trend is the attempt to link MD with more eating disorder 
psychopathology (Griffiths et al., 2015; Mitchell et al., 2017), and the most frequent 
relationships with MD amongst the included studies in this systematic review were with 
symptoms of eating disorders. Such attempts have also been reported prior to 2013 (e.g., 
Murray, et al., 2010; Murray et al., 2012). Even though there is evidence to support the 
association between BDD and MD (e.g., Hitzeroth et al., 2001; Phillips & Diaz, 1997; Pope et 
al., 1997; Pope et al., 2005), more recent research questions the current proposed MD criteria 
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(Dos Santos Filho, 2016; Nieuwoudt et al., 2016; Xinhong et al., 2015), and therefore it is 
suggested that the category MD may need to be re-evaluated for the best fit for diagnostic 
classification. With research neglecting the DSM-5 diagnostic criteria for MD, this limits the 
practical applications the research has in informing clinical practice. Because of the wide 
disagreement around classification amongst researchers, and lack of evidence supporting 
MD’s clinical utility, MD will not be included in the ICD-11 under the section of BDD (Veale 
& Matsunaga, 2014).  
Despite the issues in the literature on MD, researchers and practitioners in the field are 
to be acknowledged for their dedication and hard work, which has informed the current 
diagnostic criteria. With MD being a relatively recently recognized disorder, there is still a 
long way to go in terms of exploring why some individuals develop the condition and some 
do not, how this disorder affects one’s life, and defining the best classification for MD. A year 
prior to the release of the DSM-5, Murray and Touyz (2012) argued that MD have similar 
epidemiological features to eating disorders, and therefore having a better fit with this 
category than with BDD. To advance knowledge of MD, the research community is advised 
to reach a more mutual decision on classification (Suffolk et al., 2013). Aiming at associating 
MD with eating disorders and other related disorders is indeed important for scientific 
progress in the area. Though, it is just as important to endure investigating the association 
between MD and BDD, with the diagnostic criteria, as currently stated in the DSM-5.  
Future Recommendations 
A second aim of this systematic review was to provide recommendations for future 
research. Most importantly, researchers are encouraged to utilize the DSM-5 diagnostic 
criteria for MD in future research, and acknowledge the recognition through further 
investigation of the association between MD and BDD. As such, more appropriate practical 
applications may be accumulated, which will inform clinical practice. Moreover, increasing 
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and strengthening the methodological quality of the research conducted on MD is called for. 
Future research should focus more on male as well as female clinical samples in the attempt 
to discriminate between an individual ‘with’ and ‘without’ MD, but also develop and validate 
cut-off scores for the available MD measurements. With the significant absence of 
longitudinal data on MD, more research with longitudinal designs are needed (e.g., 
prospective studies). Examining participants on several occasions over time is recommended 
to help explain the temporal aspects (e.g., symptom-stability) of the condition as well as help 
explain the causality of MD. 
Also, with the lack of prospective studies of at-risk samples, limited knowledge is 
known about the consequences of MD and the reasons and background for why some 
individuals develop MD. Therefore, future research should examine participants over time to 
advance knowledge of relationships, consequences and background. Furthermore, more 
qualitative research may increase current understanding on the consequences of living with 
MD and the background and reasons for development. For example, further in-depth 
information and real-life examples from males and females with MD will be a major 
contribution to the literature. Understanding these individuals’ own perceptions and the way 
they live, rather than solely employing ‘pen and paper’ questionnaires, will advance 
understanding of the condition significantly. Utilizing qualitative approaches such as focus 
groups and semi-structured one-on-one interviews, may make it more effective in 
understanding e.g., underlying mechanisms for why an individual so desperately want bigger 
muscles, and e.g., classifying an individual with MD using diagnostic criteria, respectively.  
Due to the significant lack of studies enrolling participants under 18 years of age and 
female participants found in the current systematic review, future research may need to focus 
more on this neglected age group, as well as comparisons between different age groups and 
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gender. This might add to the understanding as to why some individuals develop MD at an 
early age and some do not, and gender-differences across MD psychopathology.  
Finally, future research may need to reach a consensus on classification of the 
disorder, so that advanced treatment options may be developed based on a global scientific 
agreement. At present, no specific MD intervention has been developed in a randomized 
control trial, which limits the alternatives for early identification and treatment. Investigators 
are encouraged to communicate with each other in the attempt to not widen the MD category 
more than it is today. The wider the category of MD, the less meaningful the category is for 
defining psychopathology, as debated previously (Suffolk et al., 2013).  
Limitations 
The current systematic review has some limitations. A limitation with the 
investigation of BDD associations with MD is that many of the included studies used MD 
specific measurements that might have supported the relationship between MD and BDD (i.e., 
the MDDI grounds on Pope et al’s 1997 diagnostic criteria for MD, which in return is 
supported through the diagnostic criteria for BDD; Hildebrandt, Langenbucher, & Schlundt, 
2004). Furthermore, there might have been an overlap in extracting the major results from the 
included studies, as relationships, consequences, background and reasons are all interrelated 
in some way. For example, a reported relationship may have accumulated authors decision to 
state it a consequence of being at risk of MD or a reason for development.  
Conclusion 
MD is an area of research receiving a significant amount of attention and research, and 
with the disorders breakthrough of official recognition as a specifier for BDD in the DSM-5 
in 2013, there is no doubt in that MD is a serious mental disorder assumed to have a negative 
impact on many peoples’ lives. Despite the recognition, and what was an unanticipated 
finding, was that none of the included studies used the DSM-5 diagnostic criteria for MD in 
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their research, and few studies acknowledged the association between MD and BDD, which is 
concerning. Additionally, with the current low methodological quality of MD research, there 
is now a significant need for strengthening the methodological quality. If not dealt with, these 
methodological limitations will continue to substantially limit knowledge advancement and 
the applications for practitioners and clinicians. Future research is encouraged to utilize the 
DSM-5 diagnostic criteria for MD, as well as adopt different research designs ranging from 
one-on-one interviews to large longitudinal studies, recruit other samples than ‘non-clinical 
recreational weightlifters’ and of both genders, and validate cut-off scores for MD 
measurements. As such, future treatment options for MD developed from diagnostic criteria 
and more robust methodologies, may be more effective in reducing symptomatology, add 
understanding to the background and reasons for MD development, and assist in preventing 
the potentially harmful consequences these individuals may experience. 
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Figure Legends 
























Figure 1. PRISMA flowchart of the inclusion process in the present systematic review.  
* studies examining only one construct of muscle dysmorphia (e.g., solely drive for 
muscularity or excessive exercise). 
 
Records identified through 
database searching 
(n = 210) 
Additional records identified 
through other sources 
(n = 0) 
Records screened 
(n = 210) 
Records excluded: 
Not meeting inclusion criteria, no 
original research or non-specific 
muscle dysmorphia research* 
(n = 161) 
Full-text articles assessed for 
eligibility 
(n = 49) 
Studies included in the present 
systematic review 
(n = 33) 
Full-text articles excluded: 
Non-specific muscle dysmorphia 
research* 
(n = 3) 
Assessed twice for eligibility- or 
replicated 
(n = 4) 
Clinical observation or case report 
studies 
(n = 3) 
Studies submitted and published 
prior to DSM-V release 































Table 1. Study descriptions, methodological quality and results in all the included studies. 
Author (year), 
country 
Methodological quality           Results 
 Design 
(measures) 
Sample (n), sex (M, F). 
Age (years) 
Relationships between MD and other 
variables 
Background/reasons Consequences Association with 
BDD 






M (83%) and F (17%; 
n=182). Age range: 14-
59 years 
Risk of MD associated with supplement 
intake (p < 0.001) 
   







Current or recent AAS 
users, M (n=122). Age: 
29.40 ± 7.11 years 
MD was strongly positively correlated 
(p<0.001) with ED (total and subscales) 
M whose AAS use is driven by 
appearance-related concerns may 
be a particularly dysfunctional 
subgroup 
  








active M´s, (n=158). 
Age: 26.94 ± 5.50 
years 
MD was significantly (p<0.01) 
correlated with media and peer 
influence, teasing, bulimia, BD, DFT, 
and SPP 
Vulnerability to MD and ED 
depend on pre-existing 
perfectionistic attitudes, particularly 










(n=1150), 62.8% were 
M and 32.9% F. Age: 
21.8 ± 4.0 years (M), 
22.2 ± 4.4 years (F) 
Significant strong correlation between 
having BDD and using supplements to 
get thinner and MD to get more muscular 
(p< 0.001) 
  The prevalence 
rate of BDD was 
13.0% in M and 
21.7% in F. The 
prevalence of MD 
was 12.7% in M 
and 4.2% in F 





Regular gym-goers, M 
(n=141). Age range: 
18-45 years 
Daily protein intake was greater in 
patients with MD compared to patients 
without MD 
 Individuals with MD: 
protein intake exceed the 










College students, M 
(n=117). Age: 19.89 ± 
1.17 years 
M perceived distant and M peers as 
having the most exaggerated preferences 
for muscularity and that those 
perceptions were not an accurate 
reflection of their distant M peers' 
reported preferences 
Perceptions of close F peer 
muscularity preferences were 
predictive of symptoms of MD, but 
did not exist for other peer groups, 
suggesting that the perceptions of 
close F peer preferences may play a 











(n=648). Age: 29.5 ± 
10.1 years 
Significant correlations and associations 
were detected between MD and BDD, 
and MD and ED’s 
  36 participants 
(5.6%) were at 
risk of having 
both MD and 
BDD. This may 
reflect a shared 
pathogenesis 
between MD, 
BDD, and ED’s 









Students, M (n=179) 
and F (n=313). Age: 
19.36 ± 2.76 years 
Positive beliefs about AN and MD 
significantly associated with more ED 
symptoms for both M and F participants 
Among young M’s and F’s, positive 
beliefs about AN and MD may 
contribute to the development and 
maintenance of these conditions 
 Authors link MD 
strongly to AN  
providing a 
parallel with ED’s 








Weightlifters, F (n=74), 
of which ‘expert 
bodybuilders’ (n=26), 
‘novice bodybuilders’ 
(n=29), ‘fitness lifters’ 
(n=19). Age range: 18-
48 years 
  F bodybuilders seem to 
be more at risk for 
exercise dependence and 
MD symptoms than F 














(n=294). Age: 20.5 ± 
3.1 years 
Quality of life was correlated positively 
with muscle satisfaction and 
bodybuilding dependence but negatively 
with body image coping (p<0.05). Body 
image coping was correlated positively 
with bodybuilding dependence and 
negatively with muscle satisfaction 
(p<0.05) 
 Muscularity concerns 
might influence body 
image-related quality of 
life 
 








Students, M,F (n=440). 
Age: 19.8 ± 1.96 years 
 The prevalence of EDs, orthorexia, 
and MD was 9.1%, 25.9%, and 
5.9%. Those attending the Dietetics 
school showed higher risk of EDs 
and those from the Exercise and 
Sport Sciences school higher MD 
Students with traits of 
MD were more 












of whom M (n=562), F 
(n=172). Age: 30.92 ± 
9.41 years 
Muscle dissatisfaction and self-image 
(p< .01): Participants dissatisfied with 
their muscles have devalued physical 
perceptions, physical attractiveness and 
PSC of themselves  
 Individuals suffering 
from MD symptoms, 
overall, have poorer PSC 
perceptions (p< .01) 
 






6; two scales 
of muscular 
perceptions) 
Weight training, M 
(n=146). Age: 22.8 ± 
5.0 years 
 Perceived ideal physique predicted 
MD through drive for muscularity, 
and size/symmetry concerns and 
physique protection through drive 
for muscularity and social physique 
anxiety (p ≤ 0.05) 
  







Competitive (n = 85), 
M (n = 55), F (n = 30) 
and non-competitive (n 
= 44), M (n = 24), F (n 
= 24) weight training 
athletes. Age: 31 ± 12 
years 
 Athletes focused on appearance 
enhancement scored significantly 
higher than athletes focused on 
performance enhancement on all 6 
subscales (p < 0.01) 
M scored significantly 
higher than F on the 
supplement, physique 
protection, body size and 
symmetry. Competitive 
athletes scored 
significantly higher than 
noncompetitive athletes 
did on diet, supplement, 
exercise dependence, and 
body size and symmetry 
(p < 0.05) 
 













University students, M 
(n=472). Age range: 
18-28 years in 90.4% 
of the total sample 
Students-MD relationship: Authors 
identified possible MD in 6.99% (n = 
33) of the sample 
 Participants at risk of 
MD were mainly 
characterized by 
disordered eating and 
physical exercise. They 
also had lower self-
esteem, higher anxiety in 
social interaction and 
greater use of food 
supplements  
 





Regular gym-goers, M 
(n=141). Age range: 
18-45 years 
Significant relationship between MD and 
BMI (p<0.05). MD identified in 25% of 
the normal weight, 33.3% in overweight 
and 85.7% in obese participants  
   










(n=343) of which M 
(n=113), F (n=230). 
Age range: 16-40 
(19.24 ± 2.9) years 
F’s with AN may be vulnerable to 
stigmatization, especially by M’s. AN 
and MD are perceived as “F” and “M” 
disorders, in line with societal gender 
role expectations, and this stigmatization 
is tied more strongly to perceptions of 
sufferers' masculinity than femininity 
   
Hernández-









(n=32). Age range: 13-
40 (23.22 ± 7.99) years 
Low PSC, substance use, and muscle 
checking correlated with MD (p<0.05) 
Existence of body dissatisfaction 
and muscle perception among 
weightlifters that does not equate to 
reality. Weightlifters use 
substances, display obsessive 
muscle checking behaviours, and 
have low general PSC that stems 
from their muscle (dis)satisfaction 
  









(n=304). Age: 22.49 ± 
4.38 years 
 Men with higher levels of 
alexithymia are more likely to 












(n=1039), F (63%), M 
(37%). Age: 35.10 ± 
.38 years 
A drive for muscularity and MD were 
significantly, positively correlated with 
internalization of thin ideals, 
muscular/athletic ideals, family and peer 
pressures, psychopathologic variables, 
but not media pressures 











Pope (1997) diagnosed 
individuals with MD 
(n=30), M (n=18), F 
(n=12). Age range: 19-
55 years 
  Individuals with MD 
have a negative self-
image and tend to not be 
able to change them 
MD is supported 
through BDD and 
diagnostic criteria 
set out at present 





homosexuals, M (n=?). 
Age range: 15-19 years 
MD correlated with self-disclosure of 
family members and media pressure 
Adolescents (17-19 years) had the 
highest mean scores on all 
dimensions of the MASS, 
compared with adolescents (15-16 
years) 
  





(n=170). Age range: 
 Link between the risk of developing 
MD and having an insecure 
  
(MDDI; ASQ) 18-62 (29.53 ± 8.79) 
years 
avoidant attachment style. This 
finding suggests that non-optimal 
relationships with caregivers early 
in life can be a risk factor for 
developing MD later in life 








current weight trainers 
(n=78), former weight 
trainers (n=28), never 
weight trained (n=11). 
Age range: 18-58 
(26.02 ± 8.16) years 
Male body attitudes were significantly 
associated with indications of MD. No 
significant association was found 
between narcissism and MD (p< .01) 
 
Current weight trainers reported 
more positive body attitudes than 
former weight trainers. Former 
weight trainers reported 
significantly more negative body 
attitudes compared with M who 
currently weight train if training 
frequency was reported as once per 
week or less  
  







Collegiate, M (n=114). 
Age: 21.51 ± 2.51 
years 
Function and comfort were the most 
cited reasons for clothing worn, although 
upper body clothing elicited more 
responses directed toward participants’ 
appearance 
 Physique protection 
needs to be better defined 
and understood before it 
should be considered a 
trait of MD 
 






Participants, M (n=77). 
Age range: 18-46 years 
 M’s approach MD from two 
directions, those who see 
themselves as too thin and want to 
be more muscular, and those who 
see themselves as too heavy and 
want to be more muscular  
High-MD M displayed 
significantly greater 
distance between Actual 
and Ideal Selves than did 
low-MD M 
 







students, M (n=118). 
Age range: 18-39 
(19.25 ± 3.67) years 
Significant relationships between 
severity level of negative comment on 
body and MD symptoms were found. 
More negative reactions on comments 
were associated with higher levels of 
MD symptoms 
No significant differences were 
found on MD symptoms between 
participants who recalled comments 
about their bodies and those who 
did not recall such comments.  
  
JIN Xinhong 








(n=782). Age: ? 
MD and BDD, ED and social anxiety 
were positively correlated (P< 0.01), 
showing a high rate of associated 
morbidity 
  BDD, ED and 
social anxiety 
have a certain 
predictive effect 











Resistance trainers, M 
(n=48). Age: 18  
years 
 MD represented a syndrome of 
frequently co-occurring symptoms; 
there was a significant probability 
(>.70) of a participant with one 
diagnostic symptom of MD 
(criterion 2a or 3) to exhibit another 
symptom (criterion 1) of MD 















(n=145). Age: 30 ± 9.1 
years 
The Competitiveness dimension and 
AAS intake not related to MD, while age 
appeared to be more significant 
Bodybuilders at risk of MD display 
greater global psychopathology and 
present higher scores on all SCL-
90-R dimensions when compared to 






(MDI items 6 
and 11; MDDI 
items 17 and 
18) 
Physically active, M 
(n=100). Age: 24.2 ± 
3.8 years 
Social withdrawal associated with social 
comparison tendencies 
 M with risk of MD 
showed lesser desire for 
social interaction than M 
with no risk, which can 












M (n=60). Age: 29.6 ± 
7.1 years 
ED scores, rate of pre-competition 
weight loss and number of competitions 
were significant predictors of MD. EAT- 
26 and MDDI associated and 
underscores the salience of disordered 
eating pathology in presentations of MD 
  Authors compare 










(n=562), F (n=172). 
Age range: 16-62 years 
MD associated with AAS use. 50% of M 
and F participants used or had used AAS 
   
Note. ± = Mean ± standard deviations; AAS = anabolic androgenic steroids; ACL = Adjective Check List; AN = anorexia nervosa; ASAB = Assessment of Stigmatizing Attitudes Beliefs; ASQ 
= Attachment Style Questionnaire; BAS = Body Assessment Scale; BCS = Body Comparison Scale; BD = body dissatisfaction; BD = Bodybuilding Dependence; BDD = body dysmorphic 
disorder; BDDQ = Body Dysmorphic Disorder Questionnaire; BDDS = Body Dysmorphic Disorder Scale; BDS = Bodybuilding Dependence Scale; BICSI = Body Image Coping Strategies 
Inventory; BIQLI = Body Image Quality of Life Inventory; BMI = body mass index; BSQ = Body Shape Questionnaire; DCQ = Dysmorphia Concern Questionnaire; DES-II = Dissociative 
Experience Scale – II; DFT = drive for thinness; DMAQ = Drive for Muscularity Attitudes Questionnaire; DMS-S = Drive for Muscularity Scale-Spanish Version; DSS = Dietary Supplement 
Survey; EAT-26 = Eating Attitudes Test-26; ED = eating disorder; EDE-Q = Eating Disorder Examination Questionnaire; EDI-3 = Eating Disorder Inventory-3; EDQ = Exercise Dependence 
Questionnaire; EDS = Exercise Dependence Scale; ESM = Escala de Satisfacción Muscular; F = female; FRS = Figure Rating Scale; IAS = Interaction Anxiousness Scale; M = male; MASS = 
Muscle Appearance Satisfaction Scale; MAWI = Male Attire Workout Inventory; MBAS-R = Male Body Attitudes Scale-Revised; MBAS-S = Male Body Attitudes Scale-Spanish Version; MD 
= muscle dysmorphia; MDDI = Muscle Dysmorphic Disorder Inventory; MDI = Muscle Dysmorphia Inventory; MDQ = Muscle Dysmorphia Questionnaire; MDSQ = Muscle Dysmorphia 
 
Symptom Questionnaire; MPDS = Modified Pubertal Development Scale; MPS = Multidimensional Perfectionism Scale; MS = Muscle Satisfaction; NPI-40 = Narcissistic Personality 
Characteristics-40; ORTO-15 = Questionnaire for the Diagnosis of Orthorexia; PSC = physical self-concept; PSCQ = Physical Self-Concept Questionnaire; PSWQ = Penn State Worry 
Questionnaire; RSE = Rosenberg Self-Esteem Scale; SATAQ-4 = Sociocultural Attitudes Towards Appearance Questionnaire; SCL-90-R = Symptom Checklist 90-revised; SFQ = Sociocultural 
Factors Questionnaire; SHQ = Social Hassles Questionnaire; SIAS = Social Interaction Anxiety Scale;SM = Somatomorphic Matrix.SPP = socially prescribed perfectionism; SSD = set shifting 
difficulties; TAS-20 = Toronto Alexithymia Scale-20 item.  
